|Bid||0.00 x 900|
|Ask||0.00 x 1000|
|Day's Range||145.83 - 147.64|
|52 Week Range||84.80 - 147.68|
|Beta (5Y Monthly)||1.01|
|PE Ratio (TTM)||49.04|
|Forward Dividend & Yield||0.78 (0.53%)|
|Ex-Dividend Date||Jul 02, 2021|
|1y Target Est||N/A|
SANTA CLARA, Calif., Jun 22, 2021--Agilent Technologies Inc. (NYSE: A) today announced the launch of three InfinityLab Bio LC systems specifically developed to meet the needs of the biopharma industry. The release is central to the Agilent portfolio of complete Bio LC solutions, featuring instruments, columns, and supplies that seamlessly integrate with Agilent OpenLab and MassHunter software, and CrossLab services to maximize efficiency in biopharma labs.
SANTA CLARA, Calif., Jun 14, 2021--Agilent Technologies Inc. (NYSE: A) today announced that Stéphane Bayen has received an Agilent Thought Leader Award. Dr. Bayen is an Associate Professor in the Department of Food Science and Agricultural Chemistry at McGill University in Montreal, Quebec, Canada.
Agilent Technologies Inc. (NYSE: A) today announced a presentation by Memorial Sloan Kettering Cancer Center (MSK) at the upcoming annual meeting of the American Society of Clinical Oncology (ASCO) to discuss the Resolution ctDx Lung, a laboratory-developed test (LDT) developed by Resolution Bioscience.